Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery

Drug Delivery

GlobalData says acute myeloid leukemia market will cross $1.5bn by 2026 The acute myeloid leukemia (AML) market in the seven major countries (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will grow more than three times from $406m in 2016 to more than $1.5bn by 2026, reflecting a compound annual growth rate of 14%, as per research and consulting firm GlobalData.
Drug Research > Drug Delivery > News
Sarepta, BioMarin settle patent litigation over DMD exon-skipping drugs By PBR Staff Writer
Sarepta Therapeutics and BioMarin Pharmaceutical have settled a global patent litigation relating to the use of the former’s Exondys 51 and all future exon-skipping products for the treatment of Duchenne muscular dystrophy (DMD).
Drug Research > Drug Delivery > News Sanofi to buy US vaccines biotechnology firm Protein Sciences By PBR Staff Writer
French drugmaker Sanofi has agreed to acquire US vaccines biotechnology firm Protein Sciences for around $650m.
Drug Research > Drug Delivery > News
See more Drug Delivery news

Latest Drug Delivery News and Insight

View all Drug Delivery news or find news targeted to your interests
Vetter Development Service Chicago
| By Vetter Pharma International
Our premium manufacturing and clinical supply site near Chicago, Illinois, has the people, processes, and technology to serve pharma and biotech companies of every size with customizable solutions for drug compounds in any stage from Preclinical Testing to Phase II and beyond.
Drug Research > Drug Delivery > White Papers
Vetter-Ject® Syringe Closure System
| By Vetter Pharma International
Today’s complex, sensitive biologic compounds demand new, innovative delivery systems. The Vetter-Ject® closure system allows you to offer the convenience of a syringe in a design that addresses the unique requirements of highly sensitive compounds.
Drug Research > Drug Delivery > White Papers
Vetter and Microdermics Enter into a Strategic Cooperation Agreement to Develop Innovative Microneedle Drug Delivery Systems
Vetter, a leading and innovative provider of aseptic prefilled drug delivery systems and Microdermics Inc., a Vancouver-based medical device company developing a novel hollow, metal microneedle drug and vaccine delivery system, today announced that they have entered into a strategic cooperation agreement.
Drug Research > Drug Delivery > Press Releases
Sanofi to buy US vaccines biotechnology firm Protein Sciences
By PBR Staff Writer
French drugmaker Sanofi has agreed to acquire US vaccines biotechnology firm Protein Sciences for around $650m.
Drug Research > Drug Delivery > News
View all Drug Delivery news or find news targeted to your interests